PT2881108T - Improved medicinal aerosol formulations - Google Patents
Improved medicinal aerosol formulationsInfo
- Publication number
- PT2881108T PT2881108T PT141998815T PT14199881T PT2881108T PT 2881108 T PT2881108 T PT 2881108T PT 141998815 T PT141998815 T PT 141998815T PT 14199881 T PT14199881 T PT 14199881T PT 2881108 T PT2881108 T PT 2881108T
- Authority
- PT
- Portugal
- Prior art keywords
- aerosol formulations
- medicinal aerosol
- improved medicinal
- improved
- formulations
- Prior art date
Links
- 239000000443 aerosol Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0918149.6A GB0918149D0 (en) | 2009-10-16 | 2009-10-16 | Improved medicinal aerosol formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2881108T true PT2881108T (en) | 2024-03-13 |
Family
ID=41462450
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT10768922T PT2488158E (en) | 2009-10-16 | 2010-10-15 | Improved medicinal aerosol formulations |
| PT141998815T PT2881108T (en) | 2009-10-16 | 2010-10-15 | Improved medicinal aerosol formulations |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT10768922T PT2488158E (en) | 2009-10-16 | 2010-10-15 | Improved medicinal aerosol formulations |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US20120282189A1 (en) |
| EP (3) | EP2881108B1 (en) |
| JP (5) | JP2013507430A (en) |
| CN (1) | CN102665675B (en) |
| AU (1) | AU2010305698C9 (en) |
| BR (1) | BR112012008983A2 (en) |
| CA (1) | CA2776359C (en) |
| CL (1) | CL2012000947A1 (en) |
| CY (1) | CY1116109T1 (en) |
| DK (2) | DK2488158T3 (en) |
| ES (2) | ES2973882T3 (en) |
| FI (1) | FI2881108T3 (en) |
| GB (1) | GB0918149D0 (en) |
| HK (2) | HK1173077A1 (en) |
| HR (2) | HRP20240402T1 (en) |
| HU (1) | HUE065583T2 (en) |
| IL (1) | IL219161B (en) |
| LT (1) | LT2881108T (en) |
| MX (1) | MX2012004337A (en) |
| NZ (1) | NZ599901A (en) |
| PL (2) | PL2881108T3 (en) |
| PT (2) | PT2488158E (en) |
| RS (2) | RS65391B1 (en) |
| SI (2) | SI2488158T1 (en) |
| SM (1) | SMT201500052B (en) |
| WO (1) | WO2011045432A1 (en) |
| ZA (1) | ZA201202452B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU229798B1 (en) * | 2001-03-30 | 2014-07-28 | Jagotec Ag | Medical aerosol compositions and process for their preparation |
| GB0323684D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| GB0918149D0 (en) | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
| TWI495466B (en) * | 2010-09-23 | 2015-08-11 | Intech Biopharm Ltd | Inhaled combination product for asthma |
| GB201515310D0 (en) * | 2015-08-27 | 2015-10-14 | Jagotec Ag | Pharmaceutical composition |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2503962A1 (en) | 1975-01-31 | 1976-08-05 | Thomae Gmbh Dr K | Sprays for application to skin - consisting of suspension of amorphous solids in volatile liq. carrier |
| FR2420972A1 (en) | 1978-03-31 | 1979-10-26 | Roussel Uclaf | APPLICATION OF THENOYL PEROXIDE AS A MEDICINAL PRODUCT |
| JPS5529524A (en) | 1978-08-21 | 1980-03-01 | Toyo Aerosol Kogyo Kk | Powdery aerosol composition |
| DE2914181C2 (en) | 1979-04-07 | 1982-06-16 | Kernforschungsanlage Jülich GmbH, 5170 Jülich | Method and device for drying temperature-sensitive goods in the pharmaceutical and food industries |
| JPS6135815A (en) | 1984-07-28 | 1986-02-20 | Sanshin Seisakusho:Kk | Method and apparatus for draining liquid in machine body in upper part liquid collection type filter press |
| FR2666962B1 (en) | 1990-09-26 | 1996-06-14 | Oreal | ANTIFUNGAL COMPOSITION IN THE FORM OF DRY SPRAY. |
| SE9302777D0 (en) | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
| US5874063A (en) | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
| SE9101090D0 (en) | 1991-04-11 | 1991-04-11 | Astra Ab | PROCESS FOR CONDITIONING OF WATER-SOLUBLE SUBSTANCES |
| ATE150296T1 (en) * | 1991-12-18 | 1997-04-15 | Minnesota Mining & Mfg | AEROSOL COMPOSITIONS FOR MEDICINAL SUSPENSIONS |
| DE4321288A1 (en) | 1993-06-26 | 1995-01-05 | Solvay Fluor & Derivate | Compositions with chlorine-free, optionally hydrogen-containing fluorocarbons |
| US6596260B1 (en) | 1993-08-27 | 2003-07-22 | Novartis Corporation | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
| EP0731688B1 (en) | 1993-12-02 | 2003-03-05 | Abbott Laboratories | Aerosol drug formulations for use with non-cfc propellants |
| ES2206572T3 (en) | 1995-04-14 | 2004-05-16 | Smithkline Beecham Corporation | DOSE INHALER MEASURE FOR SALMETEROL. |
| JP3707107B2 (en) | 1995-09-18 | 2005-10-19 | 鈴木油脂工業株式会社 | Pharmaceutical dispersion and method for producing the same |
| US6054488A (en) | 1996-06-11 | 2000-04-25 | 3M Innovative Properties Company | Medicinal aerosol formulations of formoterol |
| US6361938B1 (en) | 1996-11-08 | 2002-03-26 | Elan Corporation, Plc | Peptides which enhance transport across tissues and methods of identifying and using the same |
| WO1998033479A1 (en) | 1997-01-30 | 1998-08-06 | Alpenstock Holdings Limited | Haemostatic aerosol composition |
| CA2280099C (en) | 1997-02-05 | 2005-12-27 | Jago Pharma Ag | Medical aerosol formulations |
| US6086376A (en) | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
| US6451285B2 (en) | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
| CA2338753C (en) | 1998-07-24 | 2006-11-21 | Jago Research Ag | Medicinal aerosol formulations |
| US6475467B1 (en) * | 1998-08-04 | 2002-11-05 | Jago Research Ag | Medicinal aerosol formulations |
| US7521068B2 (en) | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
| EP1131059B1 (en) | 1998-11-13 | 2003-03-05 | Jago Research Ag | Dry powder for inhalation |
| US7074388B2 (en) * | 1998-12-10 | 2006-07-11 | Kos Life Science, Inc. | Water stabilized medicinal aerosol formulation |
| US6926911B1 (en) | 1998-12-22 | 2005-08-09 | The University Of North Carolina At Chapel Hill | Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs |
| AU2879100A (en) | 1999-02-12 | 2000-08-29 | Miles A. Libbey Iii | Formulation and system for intra-oral delivery of pharmaceutical agents |
| GB9903759D0 (en) | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
| GB9904919D0 (en) | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
| GB0012261D0 (en) | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel process |
| GB0012260D0 (en) | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
| US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
| ME00220B (en) | 2000-05-22 | 2010-10-10 | Chiesi Farm Spa | Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| AU2001247123A1 (en) * | 2000-07-19 | 2002-02-05 | Aeropharm Technology, Inc. | A medicinal aerosol formulation |
| CA2417973A1 (en) | 2000-08-04 | 2002-02-14 | Longwood Pharmaceutical Research, Inc. | Formulations of mometasone and a bronchodilator for pulmonary administration |
| IL155088A0 (en) | 2000-10-09 | 2003-10-31 | 3M Innovative Properties Co | Medicinal aerosol formulations |
| HU229798B1 (en) | 2001-03-30 | 2014-07-28 | Jagotec Ag | Medical aerosol compositions and process for their preparation |
| US6455028B1 (en) | 2001-04-23 | 2002-09-24 | Pharmascience | Ipratropium formulation for pulmonary inhalation |
| GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
| AR036358A1 (en) | 2001-08-28 | 2004-09-01 | Schering Corp | A DOSE INHALER MEASURES CONTAINING A SUSPENSION FORMULATION IN AEROSOL FOR INHALATION, A PROCESS FOR THE PRODUCTION OF THE FORMULATION, THE PRODUCT AND THE USE OF A FORMULATION FOR THE MANUFACTURE OF AN ASTHMA MEDICINAL PRODUCT |
| GB0201400D0 (en) | 2002-01-22 | 2002-03-13 | Glaxo Group Ltd | Novel apparatus and process |
| PT3536344T (en) | 2002-03-01 | 2020-03-26 | Chiesi Farm Spa | Formoterol superfine formulation |
| GB0207899D0 (en) | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and cielesonide aerosol formulations |
| US7582284B2 (en) | 2002-04-17 | 2009-09-01 | Nektar Therapeutics | Particulate materials |
| NZ538493A (en) * | 2002-08-29 | 2007-10-26 | Cipla Ltd | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids |
| US20060193610A1 (en) | 2003-07-12 | 2006-08-31 | Jong-Hun Han | Aromatic emitting apparatus for using cigarjack |
| JP2007505921A (en) | 2003-09-19 | 2007-03-15 | ペンウェスト ファーマシューティカルズ カンパニー | Delayed release dosage form |
| GB0323684D0 (en) * | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| GB0323685D0 (en) * | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| ES2317306T3 (en) * | 2004-10-12 | 2009-04-16 | Generics (Uk) Limited | PROCEDURE FOR THE PREPARATION OF FORMULATIONS IN AEROSOL IN SUSPENSION, IN WHICH THE PARTICLES ARE FORMED BY PRECIPITATION WITHIN AN AEROSOL FLASK. |
| GB0918150D0 (en) * | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved formulations |
| GB0918149D0 (en) | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
| JP2015036045A (en) * | 2013-08-12 | 2015-02-23 | 株式会社泉技研 | Ultrasonic acoustic system for ossein improvement and activation method for ultrasonic acoustic apparatus |
| JP6135815B1 (en) | 2016-09-29 | 2017-05-31 | 東洋インキＳｃホールディングス株式会社 | Printed wiring boards and electronic devices |
-
2009
- 2009-10-16 GB GBGB0918149.6A patent/GB0918149D0/en not_active Ceased
-
2010
- 2010-10-15 CA CA2776359A patent/CA2776359C/en active Active
- 2010-10-15 EP EP14199881.5A patent/EP2881108B1/en active Active
- 2010-10-15 RS RS20240366A patent/RS65391B1/en unknown
- 2010-10-15 US US13/503,245 patent/US20120282189A1/en not_active Abandoned
- 2010-10-15 RS RS20150160A patent/RS53883B1/en unknown
- 2010-10-15 FI FIEP14199881.5T patent/FI2881108T3/en active
- 2010-10-15 LT LTEP14199881.5T patent/LT2881108T/en unknown
- 2010-10-15 EP EP10768922.6A patent/EP2488158B1/en not_active Revoked
- 2010-10-15 PL PL14199881.5T patent/PL2881108T3/en unknown
- 2010-10-15 ES ES14199881T patent/ES2973882T3/en active Active
- 2010-10-15 BR BR112012008983A patent/BR112012008983A2/en not_active Application Discontinuation
- 2010-10-15 SI SI201030889T patent/SI2488158T1/en unknown
- 2010-10-15 PL PL10768922T patent/PL2488158T3/en unknown
- 2010-10-15 PT PT10768922T patent/PT2488158E/en unknown
- 2010-10-15 WO PCT/EP2010/065573 patent/WO2011045432A1/en active Application Filing
- 2010-10-15 AU AU2010305698A patent/AU2010305698C9/en active Active
- 2010-10-15 CN CN201080046310.7A patent/CN102665675B/en active Active
- 2010-10-15 DK DK10768922T patent/DK2488158T3/en active
- 2010-10-15 DK DK14199881.5T patent/DK2881108T3/en active
- 2010-10-15 NZ NZ599901A patent/NZ599901A/en unknown
- 2010-10-15 SI SI201032141T patent/SI2881108T1/en unknown
- 2010-10-15 MX MX2012004337A patent/MX2012004337A/en active IP Right Grant
- 2010-10-15 HR HRP20240402TT patent/HRP20240402T1/en unknown
- 2010-10-15 JP JP2012533650A patent/JP2013507430A/en active Pending
- 2010-10-15 ES ES10768922.6T patent/ES2533372T3/en active Active
- 2010-10-15 PT PT141998815T patent/PT2881108T/en unknown
- 2010-10-15 HU HUE14199881A patent/HUE065583T2/en unknown
- 2010-10-15 EP EP23219752.5A patent/EP4327807A3/en active Pending
-
2012
- 2012-04-04 ZA ZA2012/02452A patent/ZA201202452B/en unknown
- 2012-04-13 CL CL2012000947A patent/CL2012000947A1/en unknown
- 2012-04-15 IL IL219161A patent/IL219161B/en active IP Right Grant
-
2013
- 2013-01-09 HK HK13100348.4A patent/HK1173077A1/en not_active IP Right Cessation
-
2014
- 2014-05-16 US US14/279,751 patent/US20140314684A1/en not_active Abandoned
-
2015
- 2015-02-16 HR HRP20150174TT patent/HRP20150174T1/en unknown
- 2015-02-26 JP JP2015036045A patent/JP2015129162A/en active Pending
- 2015-03-06 SM SM201500052T patent/SMT201500052B/en unknown
- 2015-03-13 CY CY20151100253T patent/CY1116109T1/en unknown
- 2015-12-03 HK HK15111930.3A patent/HK1211207A1/en unknown
-
2016
- 2016-09-14 US US15/265,467 patent/US10471077B2/en active Active
- 2016-12-27 JP JP2016252909A patent/JP6568511B2/en active Active
-
2019
- 2019-08-02 JP JP2019142684A patent/JP7203701B2/en active Active
-
2022
- 2022-12-27 JP JP2022209895A patent/JP2023026517A/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT3061445T (en) | Highly concentrated pharmaceutical formulations | |
| ZA201106050B (en) | Dye-polymers formulations | |
| HK1169960A1 (en) | Pharmaceutical formulation | |
| IL269369A (en) | Improved formulations | |
| EP2424509A4 (en) | Fixed dose drug combination formulations | |
| GB0919210D0 (en) | Formulations | |
| HK1211207A1 (en) | Improved medicinal aerosol formulations | |
| EP2473168A4 (en) | Pharmaceutical formulations for indibulin | |
| IL217390A0 (en) | Formulations | |
| GB201012046D0 (en) | Pharmaceutical formulations | |
| GB201012047D0 (en) | Pharmaceutical formulations | |
| GB0914989D0 (en) | Drug release formulations | |
| GB0813031D0 (en) | Pharmaceutical formulations | |
| GB0810217D0 (en) | Pharmaceutical formulations | |
| GB0914489D0 (en) | Improved formulations | |
| GB0917744D0 (en) | Formulations |